Small Regulatory RNAs: From Bench to Bedside
Small Regulatory RNAs: From Bench to Bedside
批准号:
10462420
负责人:
Thale Cross Jarvis
金额:
$0.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-04-27 至 2023-03-31
关键词:
AcademiaAddressAreaBiological ProcessBiologyBiotechnologyClinicClinicalCollaborationsDevelopmentDiagnosisDiseaseEducational workshopEnvironmentFibrosisFutureGene ExpressionGoalsHepatitisHomeostasisIndustryKidney DiseasesKnowledgeMentorsMethodologyMicroRNAsMindMolecularNew MexicoOncologyOutcomePharmacologic SubstancePhysiciansPlayPostdoctoral FellowProcessPropertyRNARNA-targeting therapyRegulator GenesResearchResearch PersonnelRoleScienceScientistSmall Interfering RNASmall RNAStudentsTechnologyTherapeuticTherapeutic AgentsTherapeutic UsesTranslationsbasebench to bedsidebench-to-bedside translationcareerclinical practicedesignfight againsthuman diseaseinterestinventionmeetingsnew therapeutic targetnovel therapeuticspostersprogramsrare genetic disordersymposiumtargeted treatmenttherapeutic RNAtoolwound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Small Regulatory RNAs: From Bench to
Bedside, organized by Drs. Frank Slack, Jörg Vogel, Ivan Martinez and Karyn Schmidt. The conference will be
held in Santa Fe, New Mexico from May 1-4, 2022.
RNA-based therapeutics are already approved for a variety of human diseases. A large and diverse set of
small regulatory RNAs have emerged as key regulators of gene expression during development and cellular
homeostasis and are frequently mis-expressed in human disease. Their small size and molecular properties
make small RNAs amenable as targets and therapeutics and provide physicians with a powerful new battery of
agents to diagnose and treat disease. However, while thousands of small RNAs are known, relatively little is
known about their roles and targets, and there is still a limited application of these molecules in the clinic. This
conference program is designed to explore the exciting biology of small regulatory RNAs and to highlight the
best current research into the role that small RNAs play in fundamental processes. Additionally, other
sessions will focus on the latest efforts to harness the power of these RNAs as agents in the fight against
disease and provide the basic understanding that will drive the invention of powerful clinical tools. Dedicated
sessions will focus on therapeutic applications of microRNA and siRNA in areas of high interest such as
oncology, as well as diverse conditions ranging from rare genetic disorders to kidney disease, fibrosis, hepatitis
and wound healing. It is anticipated that this conference will attract the many researchers working in small
RNAs to come together to engage in critical discussions that will advance the field and accelerate the bench to
bedside translation of this technology. Finally, this conference will provide a stimulating environment where
students, postdocs and junior investigators can present and discuss their research with the best minds in the
field.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1080/15476286.2023.2196046
发表时间:
2023-01
期刊:
RNA BIOLOGY
影响因子:
4.1
作者:
[Lee, Soo Mi, Winters, Michael T., Martinez, Ivan, Slack, Frank J.]
通讯作者:
Slack, Frank J.
Bioenergetics in Health and Diseases
-
批准号:10609120
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Autophagy and Neurodegeneration: Mechanisms to Therapies
-
批准号:10608666
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Adipose Tissue: Energizing Good Fat
-
批准号:10609127
-
项目类别:
-
资助金额:$2.02万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Cancer Neoantigens, Vaccines and Viruses
-
批准号:10233861
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Engineering Multi-Cellular Living Systems
-
批准号:10462913
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Malaria: Confronting Challenges From Drug Discovery to Treatment
-
批准号:10468493
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Gut-Brain Axis
-
批准号:10467819
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
The Human Microbiome: Ecology and Evolution
-
批准号:10391370
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics
-
批准号:10468419
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Progress in Vaccine Development for Infectious Diseases
-
批准号:10467880
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies
-
批准号:10462412
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Drug Delivery to the Brain: Challenges and Progress
-
批准号:10540503
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neurocircuitry of Social Behavior
-
批准号:10540465
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Resolution of Inflammation
-
批准号:10469175
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Organoids as Tools for Fundamental Discovery and Translation
-
批准号:10469084
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Novel Approaches Against Emerging Antimicrobial Resistance
-
批准号:10391767
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Precision Genome Engineering
-
批准号:10391367
-
项目类别:
-
资助金额:$2.22万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neuronal Control of Appetite
-
批准号:10468571
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Innate Immunity: Complement and Beyond
-
批准号:10464340
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Humoral Immunity: From Regulation to Dysregulation
-
批准号:10469165
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
海外基金